Vanguard Personalized Indexing Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,853 shares of REGN stock, worth $7.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,853
Previous 10,061
7.87%
Holding current value
$7.1 Million
Previous $6.38 Million
10.71%
% of portfolio
0.07%
Previous 0.1%
Shares
23 transactions
Others Institutions Holding REGN
# of Institutions
1,441Shares Held
88.9MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$6.16 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.52 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.7 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.16 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.5 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $70.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...